--> Stem Cells therapy

Stem Cells therapy

Our possibilities:

1) Induced pluripotent stem cells (also known as iPS cells or iPSCs, IP stem cells ) therapy (1)
2) Embryonic stem cells (ES cells) therapy (2)
3) Autologous stem-cells therapy (3)
4) Allogeneic stem cells therapy (4)

 

 

1) Induced pluripotent stem cells (also known as iPS cells or iPSCs, IP stem cells )

are a type of pluripotent stem cell that can be generated directly from adult cells.
The iPSC technology was pioneered by Shinya Yamanaka’s lab in Kyoto, Japan, who showed in 2006 that the introduction of four specific genes encoding transcription factors could convert adult cells into pluripotent stem cells.

Pluripotent stem cells hold promise in the field of regenerative medicine.
Because they can propagate indefinitely, as well as give rise to every other cell type in the body (such as neurons, heart, pancreatic, and liver cells), they represent a single source of cells that could be used to replace those lost to damage or disease.

The most well-known type of pluripotent stem cell is the embryonic stem cell. However, since the generation of embryonic stem cells involves destruction (or at least manipulation) of the pre-implantation stage embryo, there has been much controversy surrounding their use. Further, because embryonic stem cells can only be derived from embryos, it has so far not been feasible to create patient-matched embryonic stem cell lines.

Since iPSCs can be derived directly from adult tissues, they not only bypass the need for embryos, but can be made in a patient-matched manner, which means that each individual could have their own pluripotent stem cell line. These unlimited supplies of autologous cells could be used to generate transplants without the risk of immune rejection.

 

2) Embryonic stem cells (ES cells)
are pluripotent stem cells derived from the inner cell mass of a blastocyst, an early-stage pre-implantation embryo.
Human embryos reach the blastocyst stage 4–5 days post fertilization, at which time they consist of 50–150 cells.
Isolating the embryoblast or inner cell mass (ICM) results in destruction of the blastocyst, which raises ethical issues, including whether or not embryos at the pre-implantation stage should be considered to have the same moral or legal status as embryos in the post-implantation stage of development.

 

3) Autologous stem-cell transplantation

(also called autogenous, autogeneic, or autogenic stem-cell transplantation and abbreviated auto-SCT) is autologous transplantation of stem cells—that is, transplantation in which stem cells (undifferentiated cells from which other cell types develop) are removed from a person, stored, and later given back to that same person.

Although it is most frequently performed with hematopoietic stem cells (precursors of blood-forming cells) in hematopoietic stem cell transplantation, cardiac cells have also been used successfully to repair damage caused by heart attacks

Autologous stem-cell transplantation is distinguished from allogenic stem cell transplantation where the donor and the recipient of the stem cells are different people.

 

4) Allogeneic stem cells

In an allogeneic transplant, stem cells are collected from a matching donor and transplanted into the patient to suppress the disease and restore the patient's immune system. An allogeneic stem cell transplant is different from an autologous stem cell transplant, which uses stem cells from the patient's own body.

 

 

Induced pluripotent stem cells,iPSCs,Embryonic stem cells,Autologous stem-cells,Allogeneic stem cells therapy

 

 

Anti-Aging Stem Cells therapy

Our based rejuvenation (anti-aging) adult stem cells therapy apply to distinct categories of patient: Healthy Patients with warning signs of aging Patients with degenerative (age related) diseases Healthy Patients with warning signs of aging Expected Benefits: The expected benefits from one of our stem cell therapy programs are extensive and will vary on a case by case basis according to a patient’s condition at the time of the injection of stem cells. In general though, once the stem cells are injected in a patient’s body, it is expected that the injected stem cells will assist in the regeneration and revitalization of the patient’s main internal organs and tissues as well as assist activate the existing body stem cells. The revitalizing and improvement in the functions of major organs such as liver, heart, and kidneys as well as key systems such as the hemic and lymphatic systems will in turn help turn back the clock and make the body run more efficiently. With a marked improvement in internal organ functions, it is then expected that the aging symptoms experienced by a patient will be greatly reduced, or possibly disappear all together, and that their external health appearance, mood, energy level, as well as in many cases, sexual drive will return. At the same time, by making the internal organs and systems biologically younger and more efficient, the stem cell therapy is also assisting in delaying the aging process and the onset of a potential degenerative disease, hence the use of the term “rejuvenation” or “anti-aging” therapy.